GLUD1
Glutamate dehydrogenase 1, mitochondrial
Also known as: DHE3_HUMAN, GDH, GDH1, GLUD, hGDH1
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- P00367
- Gene
- GLUD1
- Ensembl
- ENSG00000148672
- Chromosome
- 10
- Canonical length
- 558 aa
- Protein class
- Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins
- Subcellular location
- Mitochondria
- Quaternary structure
- Homohexamer
OverviewNCBI Gene
This gene encodes glutamate dehydrogenase, which is a mitochondrial matrix enzyme that catalyzes the oxidative deamination of glutamate to alpha-ketoglutarate and ammonia. This enzyme has an important role in regulating amino acid-induced insulin secretion. It is allosterically activated by ADP and inhibited by GTP and ATP. Activating mutations in this gene are a common cause of congenital hyperinsulinism. Alternative splicing of this gene results in multiple transcript variants. The related glutamate dehydrogenase 2 gene on the human X-chromosome originated from this gene via retrotransposition and encodes a soluble form of glutamate dehydrogenase. Related pseudogenes have been identified on chromosomes 10, 18 and X. [provided by RefSeq, Jan 2016]
Canonical amino-acid sequenceUniProt
558 residues, UniProt reviewed canonical sequence.
>P00367|GLUD1
1 MYRYLGEALL LSRAGPAALG SASADSAALL GWARGQPAAA PQPGLALAAR RHYSEAVADR
61 EDDPNFFKMV EGFFDRGASI VEDKLVEDLR TRESEEQKRN RVRGILRIIK PCNHVLSLSF
121 PIRRDDGSWE VIEGYRAQHS QHRTPCKGGI RYSTDVSVDE VKALASLMTY KCAVVDVPFG
181 GAKAGVKINP KNYTDNELEK ITRRFTMELA KKGFIGPGID VPAPDMSTGE REMSWIADTY
241 ASTIGHYDIN AHACVTGKPI SQGGIHGRIS ATGRGVFHGI ENFINEASYM SILGMTPGFG
301 DKTFVVQGFG NVGLHSMRYL HRFGAKCIAV GESDGSIWNP DGIDPKELED FKLQHGSILG
361 FPKAKPYEGS ILEADCDILI PAASEKQLTK SNAPRVKAKI IAEGANGPTT PEADKIFLER
421 NIMVIPDLYL NAGGVTVSYF EWLKNLNHVS YGRLTFKYER DSNYHLLMSV QESLERKFGK
481 HGGTIPIVPT AEFQDRISGA SEKDIVHSGL AYTMERSARQ IMRTAMKYNL GLDLRTAAYV
541 NAIEKVFKVY NEAGVTFTLocalizationUniProt · AlphaFold · HPA
Whether an antibody against GLUD1 can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Intracellular
- Secreted
- No
- Transmembrane segments
- 0
- Mean surface accessibility (rSASA)
- 0.28
- Highest tissue expression
- 860 nTPM
Expression across tissuesHPA
Tissue
- liver: 860 nTPM
- kidney: 265 nTPM
- cerebral cortex: 140 nTPM
- amygdala: 124 nTPM
- basal ganglia: 122 nTPM
- prostate: 108 nTPM
Single-cell type
- astrocytes: 574 nCPM
- respiratory basal cells: 573 nCPM
- respiratory deuterosomal cells: 546 nCPM
- hepatocytes: 529 nCPM
- respiratory secretory cells: 497 nCPM
- esophageal apical cells: 392 nCPM
Immune cell
- non-classical monocyte: 14 nTPM
- myeloid DC: 12 nTPM
- NK-cell: 10 nTPM
- T-reg: 10 nTPM
- classical monocyte: 10 nTPM
- intermediate monocyte: 9.5 nTPM
Brain region
- thalamus: 319 nTPM
- spinal cord: 260 nTPM
- medulla oblongata: 258 nTPM
- midbrain: 257 nTPM
- hypothalamus: 246 nTPM
- amygdala: 244 nTPM
DiseaseUniProt · ClinVar · IEDB · PubMed
Four sources answering four different questions about GLUD1.
Disease | AllUniProt
Conditions GLUD1 is implicated in, by any mechanism.
- Hyperinsulinemic hypoglycemia, familial, 6 (HHF6) MIM:606762
Disease | GeneticClinVar
15 pathogenic / likely-pathogenic of 319 ClinVar records.
Conditions with pathogenic or likely-pathogenic variants.
- Hyperinsulinism-hyperammonemia syndrome
- Familial hyperinsulinemia
- Familial hyperinsulinism
- GLUD1-related disorder
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 0.61
- gnomAD pLI
- 0.01
- gnomAD missense Z
- 3.06
- DepMap mean gene effect
- 0.07
- DepMap dependency class
- none
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 3% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
- glutamate biosynthetic process
- glutamine metabolic process
- L-glutamate catabolic process
- positive regulation of insulin secretion
- substantia nigra development
- tricarboxylic acid metabolic process
Molecular functions
- ADP binding
- ATP binding
- glutamate dehydrogenase (NAD+) activity
- glutamate dehydrogenase (NADP+) activity
- glutamate dehydrogenase [NAD(P)+] activity
- GTP binding
- L-leucine binding
- NAD+ binding
- protein homodimerization activity
Cellular components
Protein domainsUniProt · Pfam · InterPro
- Glutamate/phenylalanine/leucine/valine/L-tryptophan dehydrogenase
- Glutamate/phenylalanine/leucine/valine/L-tryptophan dehydrogenase, C-terminal
- Glutamate/phenylalanine/leucine/valine/L-tryptophan dehydrogenase, dimerisation domain
- Leu/Phe/Val dehydrogenases active site
- NAD(P) binding domain of glutamate dehydrogenase
- NAD(P)-binding domain superfamily
- Aminoacid dehydrogenase-like, N-terminal domain superfamily
- Glutamate/Leucine/Phenylalanine/Valine dehydrogenase
- Glu/Leu/Phe/Val dehydrogenase, dimerisation domain
KeywordsUniProt
InteractionsUniProt · HPA
Protein binding partners of GLUD1 in the human serome: UniProt-annotated complex subunits plus reported interactors. Each links to its own Seroatlas record.
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads GLUD1 as an antibody target. Whether an autoantibody or antibody against GLUD1 could matter depends on whether native GLUD1 is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
GLUD1 is annotated as predominantly intracellular. Intracellular proteins are common autoantibody markers, becoming visible to the immune system after cell injury or altered processing, but are usually markers of disease rather than direct drivers.
Annotation status
The present source text does not explicitly label GLUD1 as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...